Infinity Pharmaceuticals

Infinity Pharmaceuticals Capital Intensity

The Capital Intensity Ratio of Infinity Pharmaceuticals (INFIQ) as of Nov 20, 2026 is 1,625.57 %. In the previous year, Capital Intensity Ratio was 4,563.24 % — a change of -64.38% (lower).

Capital Intensity

1,625.57 %

YoY

-64.38%

Last updated:

Capital Intensity Ratio of Infinity Pharmaceuticals is 2022 1,625.57 % . Capital Intensity Ratio of Infinity Pharmaceuticals was 2021 4,563.24 % . It decreases by -64.38% lower compared to the previous year.

The Infinity Pharmaceuticals Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2015
264.71 USD
Jan 1, 2016
672.19 USD
Jan 1, 2017
990.00 USD
Jan 1, 2018
272.40 USD
Jan 1, 2019
1,607.54 USD
Jan 1, 2020
2,287.32 USD
Jan 1, 2021
4,563.24 USD
Jan 1, 2022
1,625.57 USD
The Infinity Pharmaceuticals Capital Intensity history
YEARCapital IntensityYoY
1,625.57 %-64.38%
4,563.24 %+99.50%
2,287.32 %+42.29%
1,607.54 %+490.14%
272.40 %-72.49%
990.00 %+47.28%
672.19 %+153.93%
264.71 %+18.33%
223.70 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

Capital Intensity Ratio of Infinity Pharmaceuticals is 1,625.57 % in 2022.

Capital Intensity Ratio of Infinity Pharmaceuticals changed from 4,563.24 % to 1,625.57 %, representing a -64.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Infinity Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals